Korsana Biosciences
KRSA
37.56
+2.11
+5.95%
Korsana Biosciences
US · KRSA
#2830 by market cap
Listed 1970
37.56
+2.11
+5.95%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Wells Fargo Initiates Korsana Biosciences(KRSA.US) With Buy Rating, Announces Target Price $44Market Newswire · 2026/11/13
-
Wedbush Maintains Korsana Biosciences(KRSA.US) With Buy Rating, Maintains Target Price $44Market Newswire · 2026/11/6
-
Wedbush Initiates Korsana Biosciences(KRSA.US) With Buy Rating, Announces Target Price $44Market Newswire · 2026/10/5
-
Rating change
UBS Initiates Korsana Biosciences(KRSA.US) With Buy Rating, Announces Target Price $55Market Newswire · 2026/9/11
-
Guggenheim Initiates Korsana Biosciences(KRSA.US) With Buy Rating, Announces Target Price $70Market Newswire · 2026/9/28
-
Guggenheim Maintains Korsana Biosciences(KRSA.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/11/6
-
Rating change
TD Cowen Initiates Korsana Biosciences(KRSA.US) With Buy RatingMarket Newswire · 2026/9/14
-
Rating change
Stifel Initiates Korsana Biosciences(KRSA.US) With Buy Rating, Announces Target Price $43Market Newswire · 2026/9/14
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Korsana Biosciences discussion 0 comments